Neogen Corporation (NASDAQ:NEOG) will release earnings for its third quarter before the opening bell on Thursday, April 9.
Analysts expect the Lansing, Michigan-based company to report quarterly earnings of 5 cents per share, down from 10 cents per share in the year-ago period. The consensus estimate for Neogen's quarterly revenue is $204.62 million (it reported $220.98 million last year), according to Benzinga Pro.
On March 2, Neogen announced the sale of Genomics business to Zoetis.
Neogen shares rose 1.6% to close at $9.56 on Monday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
- Piper Sandler analyst David Westenberg maintained a Neutral rating and raised the price target from $6.5 to $10 on Jan. 12, 2026. This analyst has an accuracy rate of 68%.
- Guggenheim analyst Subbu Nambi maintained a Buy rating and increased the price target from $8 to $12 on Jan. 9, 2026. This analyst has an accuracy rate of 51%.
- CJS Securities analyst Robert Labick upgraded the stock from Market Perform to Market Outperform and a price target of $10 on Dec. 10, 2025. This analyst has an accuracy rate of 68%.
- William Blair analyst Brandon Vazquez downgraded the stock from Outperform to Market Perform on July 29, 2025. This analyst has an accuracy rate of 64%.
Considering buying NEOG stock? Here’s what analysts think:
Photo via Shutterstock
